A Very Personal Vote for Stem Cell Research In the first of two essays about embryonic stem cells, commentator Terry Smith, recently diagnosed with diabetes, is hoping President Bush won't veto the bill. Smith is a former correspondent for Newshour. We'll hear another opinion on the issue of stem cells later this week.
NPR logo

A Very Personal Vote for Stem Cell Research

  • Download
  • <iframe src="https://www.npr.org/player/embed/5566219/5566220" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
A Very Personal Vote for Stem Cell Research

A Very Personal Vote for Stem Cell Research

A Very Personal Vote for Stem Cell Research

  • Download
  • <iframe src="https://www.npr.org/player/embed/5566219/5566220" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

In the first of two essays about embryonic stem cells, commentator Terry Smith, recently diagnosed with diabetes, is hoping President Bush won't veto the bill. Smith is a former correspondent for Newshour. We'll hear another opinion on the issue of stem cells later this week.

Contrary View

ROBERT SIEGEL, host:

This week we'll hear two commentaries that express opposing views of the issue of embryonic stem cells. The first is from commentator Terry Smith.

Mr. TERRY SMITH: I was recently diagnosed as a diabetic, joining millions of other Americans who have Type-2 Diabetes, one of the fastest spreading illnesses in the nation today.

So far I've been able to control my blood-sugar level through diet, exercise and medication. I can even enjoy a glass of wine and, mother of all evils, the occasional ice cream cone. But I am aware of the frightful consequences of this disease when it gets out of control. So I play a lot of tennis and work out, not as often as I should I suppose, but more often than before this diagnosis.

No surprise then that I and many other Americans - there are an estimated twenty million diabetics - paid special attention as the Senate addressed the emotional and politically loaded issue of expanding federal funding for embryonic stem cell research. There are no guarantees, but scientific evidence suggests that such research could provide new treatments and possibly even a cure for numerous diseases, including diabetes.

After years of covering similar debates as a journalist, I've discovered that nothing brings home a public policy issue like the possibility that it could affect you. You evolve very quickly from disinterested observer to participant. I not only want to benefit myself from any treatment that might emerge from embryonic stem cell research, I want my children, Elizabeth(ph) and Christopher(ph), to share that advantage should diabetes prove to be genetic.

President Bush has repeated his opposition to this legislation as recently as this week. He has said that in his view such research, using the estimated four hundred thousand excess embryos that are currently frozen in fertility clinics, crosses an important moral line. He says this despite the fact that most of these frozen embryos would otherwise be discarded. I don't doubt his sincerity, but I do question whether we elect our political leaders to assert their moral or religious views over scientific evidence and, polls suggest, the will of the majority.

Honest men and women can differ over this question, but I have to admit my bias. I have a dog in this fight. The president has pledged to use his first veto on this legislation. I hope he listens to this debate and decides to keep his veto pen in his pocket.

SIEGEL: Terry Smith is a former media correspondent for the NewsHour. We'll hear another opinion on the issue of stem cell research tomorrow.

Copyright © 2006 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.